Mumbai: announced its financial results for the second quarter and half year ended September 30, 2026, marking its eighth consecutive quarter of margin and . The company posted a quarterly revenue of ₹11,860 crore, down 1% year-on-year.
Earnings Performance
EBITDA for the second quarter rose 5% to ₹2,312 crore with a margin expansion of 120 basis points to 19.5%. Operational PATMI stood at ₹422 crore, registering a slight increase compared to the previous year.
Segment Growth
Advanta recorded a 12% increase in quarterly revenue to ₹1,875 crore, supported by pricing and foreign exchange tailwinds. SUPERFORM delivered a 28% revenue growth to ₹3,579 crore, aided by cost pass-through and strong demand in super specialty chemicals.
Debt And Capital
Total net debt reached ₹28,684 crore at the end of September 2026. The company prepaid a term loan of USD 500 million maturing in December 2026 through a USD 400 million refinancing extended to .
Acquisition Plans
Advanta agreed to acquire a 99.98% stake in Misr Hytech Seed International in Egypt for approximately USD 110 million. The transaction is expected to be completed on or before January 31, 2027, pending regulatory approvals.